The stock exhibits a dramatic recovery from a deep downtrend, with a 1-year price change of +507.1%, though it remains well below its 52-week high of $12.49. Currently trading at $8.56, the stock sits at 68.5% of its 52-week range, suggesting it has rebounded significantly but still has room to run before challenging prior highs. The 52-week low of $1.15 highlights the extreme volatility and the stock's speculative nature. Short-term momentum shows a stark divergence: the 1-month change is -28.9%, indicating a sharp pullback from the May-June rally, while the 3-month change remains strongly positive at +104.3%. This divergence suggests the recent selloff may be a corrective retracement within a larger uptrend, but the speed of the decline warrants caution. The beta of 2.166 confirms the stock is more than twice as volatile as the S&P 500, amplifying both upside and downside moves. Key support lies near the 52-week low of $1.15, while resistance is at the 52-week high of $12.49. A breakout above $12.49 would signal a resumption of the uptrend, while a breakdown below recent lows could test the $4-5 area. The elevated beta means position sizing should account for potential swings of 10% or more in short periods.

Revenue has grown rapidly from zero in early 2024 to $90.4 million in Q3 2025, reflecting the ramp-up of solar module production. However, the trajectory is uneven: Q2 2025 revenue was $66.5 million, and Q1 2025 was $64.6 million, indicating sequential growth is decelerating. The company remains unprofitable, with a net loss of -$130.6 million in Q3 2025, though losses have narrowed from -$367.1 million in Q4 2024. Gross margin improved to 23.4% in Q3 2025 from negative territory in prior quarters, but operating margin remains deeply negative at -104.8%, reflecting high operating expenses relative to revenue. The balance sheet shows a debt-to-equity ratio of 1.02, indicating moderate leverage, but free cash flow turned positive at $54.9 million in Q3 2025 after being negative for several quarters. However, trailing twelve-month free cash flow is -$54.7 million, and the company has relied on equity issuance ($50 million in Q4 2024) to fund operations. ROE is deeply negative at -114.3%, reflecting persistent losses relative to shareholder equity.